Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $8.36 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.61.
Market Cap
8.36T
Revenue
4.59T
Profits
200.88B
PE Ratio
41.61
Profit Margin
4.38%
Dividend Yield
0.43%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 965.68B | 1.71% | 2,582,999 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 556.77B | 0.48% | 5,828,547 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 380.57B | 1.07% | 4,640,418 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 348.74B | 1.90% | 4,546,686 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 296.97B | 0.43% | 7,163,193 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 291.74B | -0.82% | 2,121,823 | 60.44B |
| 7 | NVS | Novartis AG | 290.16B | 0.21% | 989,020 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 200.19B | 0.81% | 11,335,112 | 50.57B |
| 9 | AMGN | Amgen Inc. | 181.37B | 0.04% | 1,929,984 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 169.54B | 1.79% | 2,958,872 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 165.99B | -0.03% | 5,032,602 | 29.74B |
| 12 | PFE | Pfizer Inc. | 149.38B | 1.39% | 39,024,676 | 63.32B |
| 13 | ABT | Abbott Laboratories | 149.24B | -1.14% | 10,814,314 | 45.13B |
| 14 | ISRG | Intuitive Surgical, Inc. | 148.23B | -4.14% | 3,125,441 | 10.58B |
| 15 | DHR | Danaher Corporation | 122.54B | 0.19% | 3,264,940 | 24.78B |
| 16 | CVS | CVS Health Corporation | 117.47B | 1.48% | 5,403,379 | 405.62B |
| 17 | BMY | Bristol-Myers Squibb Company | 117.46B | -0.88% | 9,347,512 | 48.48B |
| 18 | SYK | Stryker Corporation | 117.29B | -2.26% | 3,672,926 | 25.27B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 110.97B | 0.30% | 1,164,432 | 12.22B |
| 20 | SNY | Sanofi | 107.69B | 0.63% | 2,297,377 | 54.60B |
| 21 | GSK | GSK plc | 103.96B | 0.16% | 3,066,586 | 43.29B |
| 22 | MDT | Medtronic plc | 97.55B | -2.09% | 10,474,661 | 35.48B |
| 23 | MCK | McKesson Corporation | 90.93B | 0.27% | 1,367,289 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 86.99B | -0.07% | 975,738 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 85.01B | 0.93% | 1,337,616 | 200.42B |
| 26 | CI | The Cigna Group | 75.59B | 1.75% | 1,422,949 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 75.00B | -12.46% | 52,710,194 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.87B | -1.08% | 1,913,616 | 14.92B |
| 29 | COR | Cencora, Inc. | 51.95B | -1.39% | 1,459,096 | 328.68B |
| 30 | ARGX | argenx SE | 51.30B | 1.51% | 204,426 | 4.74B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 50.72B | 1.76% | 3,183,845 | 28.34B |
| 32 | EW | Edwards Lifesciences Corporation | 49.81B | -1.18% | 7,327,962 | 6.30B |
| 33 | MDLN | Medline Inc. | 47.08B | -0.88% | 7,471,177 | 29.14B |
| 34 | CAH | Cardinal Health, Inc. | 46.80B | -0.26% | 1,628,263 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.46B | -1.12% | 504,730 | 4.45B |
| 36 | HLN | Haleon plc | 41.25B | 0.87% | 5,558,032 | 14.85B |
| 37 | BDX | Becton, Dickinson and Company | 40.57B | -0.35% | 2,877,941 | 22.23B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 40.24B | -0.14% | 4,357,495 | 17.35B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.47B | 0.04% | 629,512 | 4.29B |
| 40 | HUM | Humana Inc. | 36.77B | 1.52% | 724,613 | 137.20B |
| 41 | WAT | Waters Corporation | 33.60B | 1.05% | 654,482 | 3.77B |
| 42 | ONC | BeOne Medicines AG | 33.35B | -0.80% | 159,054 | 5.70B |
| 43 | ZTS | Zoetis Inc. | 33.32B | -0.93% | 7,874,410 | 9.53B |
| 44 | A | Agilent Technologies, Inc. | 32.74B | 0.66% | 2,940,606 | 7.23B |
| 45 | ALC | Alcon Inc. | 32.72B | -1.99% | 2,518,252 | 10.63B |
| 46 | RVMD | Revolution Medicines, Inc. | 32.53B | -1.22% | 2,881,879 | - |
| 47 | RPRX | Royalty Pharma plc | 31.08B | 0.20% | 3,075,813 | 2.44B |
| 48 | RMD | ResMed Inc. | 29.90B | -0.90% | 1,305,524 | 5.54B |
| 49 | NTRA | Natera, Inc. | 29.09B | 1.10% | 1,273,629 | 2.50B |
| 50 | BIIB | Biogen Inc. | 29.08B | 2.01% | 893,016 | 9.94B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 29.06B | -0.47% | 3,981,539 | 20.98B |
| 52 | CNC | Centene Corporation | 29.05B | 2.81% | 3,201,090 | 178.33B |
| 53 | IQV | IQVIA Holdings Inc. | 27.64B | 2.23% | 1,400,294 | 16.63B |
| 54 | DXCM | DexCom, Inc. | 27.11B | -2.43% | 5,863,406 | 4.82B |
| 55 | VEEV | Veeva Systems Inc. | 25.87B | -0.03% | 2,236,165 | 3.20B |
| 56 | PHG | Koninklijke Philips N.V. | 25.44B | -1.26% | 1,019,503 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.23B | -1.33% | 338,710 | 3.17B |
| 58 | BNTX | BioNTech SE | 23.52B | 0.81% | 1,552,196 | 3.23B |
| 59 | INSM | Insmed Incorporated | 23.06B | -2.27% | 3,094,622 | 819.56M |
| 60 | ILMN | Illumina, Inc. | 22.72B | 3.40% | 1,891,847 | 4.39B |
| 61 | MTD | Mettler-Toledo International Inc. | 22.10B | -0.68% | 136,761 | 4.09B |
| 62 | WST | West Pharmaceutical Services, Inc. | 22.09B | -1.09% | 657,567 | 3.22B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.47B | 0.58% | 597,236 | 11.28B |
| 64 | ROIV | Roivant Sciences Ltd. | 21.28B | -0.30% | 6,699,429 | 8.26M |
| 65 | LH | Labcorp Holdings Inc. | 21.18B | -0.08% | 539,341 | 14.14B |
| 66 | STE | STERIS plc | 20.88B | -1.57% | 563,884 | 5.94B |
| 67 | INCY | Incyte Corporation | 19.45B | 0.25% | 939,616 | 5.36B |
| 68 | VTRS | Viatris Inc. | 18.97B | 0.18% | 6,781,488 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 18.89B | 1.23% | 3,599,005 | 2.23B |
| 70 | GH | Guardant Health, Inc. | 16.91B | 6.39% | 3,407,994 | 1.08B |
| 71 | GMAB | Genmab A/S | 16.48B | -0.67% | 790,752 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 15.97B | -2.19% | 1,666,878 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.67B | 0.06% | 708,584 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 15.60B | 2.65% | 1,507,782 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.91B | 0.06% | 615,351 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 14.61B | -1.83% | 353,441 | 998.25M |
| 77 | SMMT | Summit Therapeutics Inc. | 13.47B | 2.12% | 2,211,495 | - |
| 78 | SOLV | Solventum Corporation | 13.14B | -0.50% | 2,767,518 | 8.26B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 13.01B | -1.90% | 3,022,796 | 579.96M |
| 80 | SNN | Smith & Nephew plc | 12.92B | -0.72% | 1,223,619 | 6.16B |
| 81 | IONS | Ionis Pharmaceuticals, Inc. | 12.64B | 0.55% | 1,458,671 | 1.06B |
| 82 | PEN | Penumbra, Inc. | 12.60B | -2.39% | 532,643 | 1.45B |
| 83 | EXEL | Exelixis, Inc. | 12.58B | 0.10% | 2,434,866 | 2.38B |
| 84 | DVA | DaVita Inc. | 12.51B | -0.33% | 441,037 | 13.84B |
| 85 | BTSG | BrightSpring Health Services, Inc. | 12.45B | 0.38% | 1,930,470 | 13.65B |
| 86 | MEDP | Medpace Holdings, Inc. | 12.22B | -0.26% | 210,070 | 2.68B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.17B | 0.65% | 144,104 | 1.13B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 12.07B | 0.14% | 708,939 | 708.24M |
| 89 | COO | The Cooper Companies, Inc. | 11.86B | -1.98% | 2,032,930 | 4.15B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.83B | 3.81% | 8,281,083 | 4.89B |
| 91 | RGC | Regencell Bioscience Holdings Limited | 11.75B | -2.47% | 138,017 | - |
| 92 | ALGN | Align Technology, Inc. | 11.67B | -0.41% | 1,553,536 | 4.10B |
| 93 | FMS | Fresenius Medical Care AG | 11.59B | -0.09% | 1,288,567 | 22.32B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.47B | -1.24% | 2,159,787 | 3.58B |
| 95 | GMED | Globus Medical, Inc. | 11.20B | -3.01% | 2,408,739 | 3.10B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.13B | 0.39% | 1,288,329 | 622.01M |
| 97 | RVTY | Revvity, Inc. | 10.80B | -0.04% | 924,952 | 2.90B |
| 98 | CYTK | Cytokinetics, Incorporated | 10.47B | 1.13% | 1,622,202 | 105.82M |
| 99 | ABVX | ABIVAX Société Anonyme | 10.42B | 2.63% | 1,082,598 | 5.67M |
| 100 | EHC | Encompass Health Corporation | 10.35B | -0.59% | 583,841 | 6.07B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.12B | -0.95% | 2,344,633 | 3.24B |
| 102 | PODD | Insulet Corporation | 10.11B | -5.07% | 2,507,728 | 2.90B |
| 103 | BAX | Baxter International Inc. | 9.98B | -0.26% | 8,550,385 | 11.32B |
| 104 | ENSG | The Ensign Group, Inc. | 9.97B | -0.26% | 432,838 | 5.27B |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.96B | 1.86% | 304,539 | 7.46M |
| 106 | MASI | Masimo Corporation | 9.36B | 0.06% | 790,341 | 1.56B |
| 107 | UHS | Universal Health Services, Inc. | 9.34B | -1.49% | 856,636 | 17.76B |
| 108 | MOH | Molina Healthcare, Inc. | 9.27B | 0.95% | 1,241,860 | 43.10B |
| 109 | ICLR | ICON Public Limited Company | 9.04B | 4.04% | 1,765,706 | 8.25B |
| 110 | KRYS | Krystal Biotech, Inc. | 9.04B | 1.31% | 144,305 | 417.30M |
| 111 | HSIC | Henry Schein, Inc. | 8.62B | 2.40% | 1,860,208 | 13.38B |
| 112 | NUVL | Nuvalent, Inc. | 8.48B | 2.32% | 631,653 | - |
| 113 | TEM | Tempus AI, Inc. | 8.47B | 1.09% | 3,837,976 | 1.36B |
| 114 | IBRX | ImmunityBio, Inc. | 8.26B | -0.38% | 14,532,401 | 140.98M |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 8.17B | 2.83% | 574,425 | 2.59B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.14B | -0.10% | 2,043,182 | 1.51B |
| 117 | CRL | Charles River Laboratories International, Inc. | 7.92B | 4.95% | 1,165,879 | 4.03B |
| 118 | TECH | Bio-Techne Corporation | 7.53B | 0.25% | 2,151,166 | 1.21B |
| 119 | QGEN | Qiagen N.V. | 7.47B | 1.66% | 2,252,378 | 2.10B |
| 120 | BRKR | Bruker Corporation | 7.40B | 3.62% | 2,503,941 | 3.46B |
| 121 | PCVX | Vaxcyte, Inc. | 7.37B | 1.82% | 1,413,860 | - |
| 122 | ATR | AptarGroup, Inc. | 7.36B | -0.93% | 464,058 | 3.87B |
| 123 | HQY | HealthEquity, Inc. | 7.31B | -0.79% | 937,229 | 1.31B |
| 124 | CORT | Corcept Therapeutics Incorporated | 7.15B | 10.42% | 1,890,920 | 769.10M |
| 125 | GRFS | Grifols, S.A. | 6.87B | 0.50% | 757,523 | 8.58B |
| 126 | IMVT | Immunovant, Inc. | 6.86B | -1.24% | 1,754,872 | - |
| 127 | KYMR | Kymera Therapeutics, Inc. | 6.72B | 1.15% | 330,316 | 51.48M |
| 128 | OSCR | Oscar Health, Inc. | 6.62B | 0.46% | 5,397,353 | 13.30B |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.57B | 2.23% | 404,793 | 74.06M |
| 130 | CELC | Celcuity Inc. | 6.53B | -0.22% | 646,714 | - |
| 131 | LNTH | Lantheus Holdings, Inc. | 6.45B | -0.97% | 1,608,011 | 1.55B |
| 132 | GKOS | Glaukos Corporation | 6.45B | -4.43% | 1,231,643 | 551.35M |
| 133 | RGEN | Repligen Corporation | 6.38B | -1.75% | 1,125,533 | 763.34M |
| 134 | ALKS | Alkermes plc | 6.35B | 1.98% | 2,246,972 | 1.56B |
| 135 | SYRE | Spyre Therapeutics, Inc. | 6.30B | -1.55% | 557,990 | - |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.27B | 1.78% | 495,689 | 217.17M |
| 137 | PACS | PACS Group, Inc. | 6.20B | 0.85% | 582,842 | 5.43B |
| 138 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.03% | 1,080,162 | 15.00M |
| 139 | SRRK | Scholar Rock Holding Corporation | 6.07B | -1.69% | 864,403 | - |
| 140 | MIRM | Mirum Pharmaceuticals, Inc. | 5.94B | -1.59% | 668,837 | 569.61M |
| 141 | COGT | Cogent Biosciences, Inc. | 5.90B | 1.68% | 3,093,382 | - |
| 142 | PTCT | PTC Therapeutics, Inc. | 5.86B | 4.45% | 1,692,469 | 827.11M |
| 143 | HIMS | Hims & Hers Health, Inc. | 5.83B | 5.66% | 22,756,822 | 2.37B |
| 144 | APGE | Apogee Therapeutics, Inc. | 5.83B | -6.11% | 4,032,065 | - |
| 145 | CHE | Chemed Corporation | 5.81B | 0.48% | 203,861 | 2.54B |
| 146 | TFX | Teleflex Incorporated | 5.76B | -1.39% | 637,071 | 2.13B |
| 147 | AVTR | Avantor, Inc. | 5.74B | 3.19% | 9,113,018 | 6.55B |
| 148 | BLCO | Bausch + Lomb Corporation | 5.60B | -0.38% | 297,789 | 5.21B |
| 149 | BLTE | Belite Bio, Inc | 5.59B | 0.06% | 148,753 | - |
| 150 | TGTX | TG Therapeutics, Inc. | 5.56B | -1.33% | 1,576,023 | 700.35M |
| 151 | LQDA | Liquidia Corporation | 5.52B | 3.20% | 1,350,376 | 288.07M |
| 152 | CGON | CG Oncology, Inc. | 5.36B | -1.76% | 1,029,052 | 5.07M |
| 153 | LEGN | Legend Biotech Corporation | 5.29B | -3.49% | 1,437,437 | 1.14B |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.21B | -0.15% | 2,271,059 | 7.50M |
| 155 | CRSP | CRISPR Therapeutics AG | 5.16B | 3.76% | 1,840,892 | 4.10M |
| 156 | STVN | Stevanato Group S.p.A. | 4.93B | 0.56% | 130,903 | 1.39B |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.74B | -0.17% | 560,383 | 1.34M |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 4.73B | 0.24% | 189,839 | 274.48M |
| 159 | TVTX | Travere Therapeutics, Inc. | 4.44B | 7.83% | 3,113,466 | 536.20M |
| 160 | SHC | Sotera Health Company | 4.43B | -2.63% | 2,864,840 | 1.19B |
| 161 | CAI | Caris Life Sciences, Inc. | 4.35B | -0.90% | 1,870,145 | 907.29M |
| 162 | NAMS | NewAmsterdam Pharma Company N.V. | 4.27B | 1.25% | 938,780 | 22.57M |
| 163 | RDNT | RadNet, Inc. | 4.23B | -0.52% | 496,098 | 2.14B |
| 164 | BLLN | BillionToOne, Inc. | 4.19B | 7.74% | 800,350 | 354.54M |
| 165 | MANE | Veradermics, Incorporated | 4.18B | -2.31% | 471,737 | - |
| 166 | HNGE | Hinge Health, Inc. | 4.15B | 1.13% | 990,814 | 646.34M |
| 167 | AMRX | Amneal Pharmaceuticals, Inc. | 4.08B | -0.08% | 1,525,579 | 3.05B |
| 168 | LIVN | LivaNova PLC | 4.06B | -2.02% | 1,050,574 | 1.43B |
| 169 | TWST | Twist Bioscience Corporation | 4.00B | -1.08% | 1,305,850 | 409.48M |
| 170 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.99B | -1.93% | 612,531 | 754.05M |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | 0.03% | 861,552 | 18.07M |
| 172 | ERAS | Erasca, Inc. | 3.88B | 8.43% | 6,381,763 | - |
| 173 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | -0.03% | 3,702,884 | 596.96M |
| 174 | NVST | Envista Holdings Corporation | 3.79B | -0.81% | 2,579,278 | 2.81B |
| 175 | MMSI | Merit Medical Systems, Inc. | 3.73B | -3.10% | 919,496 | 1.54B |
| 176 | DOCS | Doximity, Inc. | 3.70B | 3.79% | 3,806,578 | 644.86M |
| 177 | VKTX | Viking Therapeutics, Inc. | 3.68B | 2.79% | 1,754,485 | - |
| 178 | IRTC | iRhythm Holdings, Inc. | 3.66B | -2.67% | 768,699 | 787.85M |
| 179 | WAY | Waystar Holding Corp. | 3.66B | -3.35% | 2,716,407 | 1.16B |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.63B | -0.33% | 982,249 | 1.10B |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.61B | -0.06% | 572,802 | - |
| 182 | VCYT | Veracyte, Inc. | 3.55B | 0.63% | 1,028,890 | 541.74M |
| 183 | OGN | Organon & Co. | 3.51B | -0.22% | 3,388,573 | 6.16B |
| 184 | ORKA | Oruka Therapeutics, Inc. | 3.50B | -1.81% | 671,319 | - |
| 185 | ICUI | ICU Medical, Inc. | 3.46B | 2.50% | 325,535 | 2.16B |
| 186 | OPCH | Option Care Health, Inc. | 3.40B | 1.36% | 2,386,409 | 5.67B |
| 187 | CON | Concentra Group Holdings Parent, Inc. | 3.30B | 1.06% | 516,997 | 2.23B |
| 188 | ALHC | Alignment Healthcare, Inc. | 3.29B | -0.62% | 2,537,679 | 4.26B |
| 189 | TXG | 10x Genomics, Inc. | 3.24B | 3.61% | 3,569,460 | 638.78M |
| 190 | BKD | Brookdale Senior Living Inc. | 3.22B | 0.15% | 2,129,514 | 3.00B |
| 191 | DNLI | Denali Therapeutics Inc. | 3.21B | 4.28% | 1,625,489 | - |
| 192 | BEAM | Beam Therapeutics Inc. | 3.17B | 7.05% | 2,729,349 | 164.01M |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.16B | 1.78% | 88,617 | 803.79M |
| 194 | WRBY | Warby Parker Inc. | 3.15B | 0.67% | 1,222,122 | 890.57M |
| 195 | RLAY | Relay Therapeutics, Inc. | 3.14B | 1.83% | 3,050,364 | 10.68M |
| 196 | GRAL | GRAIL, Inc. | 3.07B | 3.57% | 661,222 | 156.12M |
| 197 | HAE | Haemonetics Corporation | 3.05B | 0.48% | 1,138,247 | 1.33B |
| 198 | MMED | MiniMed Group, Inc. | 3.03B | -3.40% | 730,738 | 2.99B |
| 199 | ITGR | Integer Holdings Corporation | 3.02B | -1.30% | 873,708 | 1.86B |
| 200 | RCUS | Arcus Biosciences, Inc. | 3.01B | -0.66% | 754,532 | 236.00M |
| 201 | DYN | Dyne Therapeutics, Inc. | 3.00B | 0.06% | 1,051,171 | - |
| 202 | NHC | National HealthCare Corporation | 3.00B | 1.05% | 103,276 | 1.53B |
| 203 | LFST | LifeStance Health Group, Inc. | 2.95B | 0.53% | 3,068,583 | 1.49B |
| 204 | TNGX | Tango Therapeutics, Inc. | 2.84B | -1.95% | 2,926,056 | 56.99M |
| 205 | KLRA | Kailera Therapeutics, Inc. | 2.84B | 1.58% | 479,489 | - |
| 206 | GPCR | Structure Therapeutics Inc. | 2.81B | -0.10% | 573,848 | - |
| 207 | PRVA | Privia Health Group, Inc. | 2.74B | -2.07% | 818,694 | 2.25B |
| 208 | ALMS | Alumis Inc. | 2.72B | -4.48% | 822,308 | 8.40M |
| 209 | SUPN | Supernus Pharmaceuticals, Inc. | 2.71B | -2.37% | 710,985 | 776.83M |
| 210 | IRON | Disc Medicine, Inc. | 2.66B | 2.41% | 333,387 | - |
| 211 | GMRS | GMR Solutions Inc. | 2.65B | 4.49% | 848,736 | 5.74B |
| 212 | ARQT | Arcutis Biotherapeutics, Inc. | 2.65B | 0.19% | 1,504,254 | 415.62M |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 2.58B | -1.80% | 562,786 | 535.08M |
| 214 | IDYA | IDEAYA Biosciences, Inc. | 2.57B | -0.24% | 577,201 | 225.27M |
| 215 | DFTX | Definium Therapeutics, Inc. | 2.57B | 2.80% | 1,780,900 | - |
| 216 | HTFL | HeartFlow, Inc. | 2.53B | 3.10% | 1,042,077 | 191.42M |
| 217 | ELVN | Enliven Therapeutics, Inc. | 2.52B | -2.63% | 519,002 | - |
| 218 | IMNM | Immunome, Inc. | 2.50B | 0.91% | 879,467 | 4.02M |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.48B | 2.59% | 503,024 | 865.00K |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.48B | 1.37% | 272,119 | 1.46B |
| 221 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | 0.07% | 1,164,254 | - |
| 222 | VERA | Vera Therapeutics, Inc. | 2.46B | -0.20% | 659,498 | - |
| 223 | TMDX | TransMedics Group, Inc. | 2.42B | -0.44% | 1,350,453 | 635.89M |
| 224 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.32B | 7.67% | 6,574,953 | 885.72M |
| 225 | RARE | Ultragenyx Pharmaceutical Inc. | 2.30B | 1.08% | 1,685,021 | 670.00M |
| 226 | PBH | Prestige Consumer Healthcare Inc. | 2.29B | 0.52% | 566,160 | 1.09B |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.22B | 2.55% | 1,444,815 | 3.37B |
| 228 | ADPT | Adaptive Biotechnologies Corporation | 2.22B | -2.05% | 2,774,424 | 295.41M |
| 229 | NKTR | Nektar Therapeutics | 2.21B | -0.24% | 1,412,095 | 55.63M |
| 230 | KOD | Kodiak Sciences Inc. | 2.19B | -2.53% | 504,266 | - |
| 231 | LMAT | LeMaitre Vascular, Inc. | 2.19B | -3.03% | 213,050 | 256.28M |
| 232 | AXGN | Axogen, Inc. | 2.12B | -3.81% | 950,592 | 238.11M |
| 233 | ZLAB | Zai Lab Limited | 2.10B | 1.30% | 716,600 | 453.28M |
| 234 | ESTA | Establishment Labs Holdings Inc. | 2.10B | -1.82% | 309,860 | 229.58M |
| 235 | PHVS | Pharvaris N.V. | 2.05B | -1.37% | 141,852 | - |
| 236 | TRVI | Trevi Therapeutics, Inc. | 2.05B | 0.49% | 774,969 | - |
| 237 | SEM | Select Medical Holdings Corporation | 2.05B | -0.18% | 1,003,832 | 5.52B |
| 238 | HCM | HUTCHMED (China) Limited | 2.04B | -0.26% | 44,216 | 548.51M |
| 239 | NBTX | Nanobiotix S.A. | 2.04B | -0.74% | 26,657 | 38.27M |
| 240 | BHC | Bausch Health Companies Inc. | 2.01B | -0.19% | 1,806,821 | 10.53B |
| 241 | XRAY | DENTSPLY SIRONA Inc. | 2.00B | 0.10% | 4,946,599 | 3.68B |
| 242 | NEOG | Neogen Corporation | 2.00B | 0.66% | 3,923,549 | 870.56M |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | 2.30% | 2,445,819 | 298.30M |
| 244 | PGNY | Progyny, Inc. | 2.00B | 1.72% | 2,256,683 | 1.29B |
| 245 | TYRA | Tyra Biosciences, Inc. | 1.97B | -1.25% | 375,700 | - |
| 246 | NVCR | NovoCure Limited | 1.97B | -6.96% | 1,481,651 | 674.41M |
| 247 | OMCL | Omnicell, Inc. | 1.96B | -2.22% | 401,846 | 1.23B |
| 248 | SION | Sionna Therapeutics, Inc. | 1.96B | 1.28% | 189,444 | - |
| 249 | STOK | Stoke Therapeutics, Inc. | 1.96B | 1.35% | 359,109 | 32.08M |
| 250 | IOVA | Iovance Biotherapeutics, Inc. | 1.95B | 6.59% | 12,819,904 | 285.61M |
| 251 | ASTH | Astrana Health, Inc. | 1.91B | -0.05% | 347,123 | 3.53B |
| 252 | VRDN | Viridian Therapeutics, Inc. | 1.91B | 1.53% | 1,157,203 | 70.92M |
| 253 | MESO | Mesoblast Limited | 1.90B | -1.61% | 193,881 | 65.38M |
| 254 | CLOV | Clover Health Investments, Corp. | 1.89B | -0.55% | 4,914,781 | 2.21B |
| 255 | RAPP | Rapport Therapeutics, Inc. | 1.89B | -0.50% | 270,246 | 20.00M |
| 256 | AAPG | Ascentage Pharma Group International | 1.88B | 3.83% | 10,113 | 82.08M |
| 257 | NTLA | Intellia Therapeutics, Inc. | 1.88B | 6.58% | 6,548,662 | 66.09M |
| 258 | OCUL | Ocular Therapeutix, Inc. | 1.87B | 3.02% | 2,569,322 | 52.04M |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 0.22% | 156,226 | 1.20B |
| 260 | ADMA | ADMA Biologics, Inc. | 1.84B | -2.82% | 3,550,279 | 509.86M |
| 261 | NVAX | Novavax, Inc. | 1.82B | 6.02% | 9,799,904 | 596.34M |
| 262 | ZYME | Zymeworks Inc. | 1.81B | -2.40% | 509,462 | 81.26M |
| 263 | NRIX | Nurix Therapeutics, Inc. | 1.81B | 0.52% | 831,495 | 71.78M |
| 264 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | 2.23% | 559,531 | 899.11M |
| 265 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | 0.06% | 2,191,206 | 2.18B |
| 266 | OCS | Oculis Holding AG | 1.75B | -1.07% | 297,478 | 1.40M |
| 267 | UFPT | UFP Technologies, Inc. | 1.75B | -1.17% | 190,051 | 608.85M |
| 268 | VCEL | Vericel Corporation | 1.75B | -2.00% | 448,879 | 292.09M |
| 269 | SGRY | Surgery Partners, Inc. | 1.75B | 0.22% | 926,729 | 3.34B |
| 270 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -1.46% | 1,051,970 | 217.17M |
| 271 | MD | Pediatrix Medical Group, Inc. | 1.74B | 0.42% | 563,384 | 1.93B |
| 272 | SNDA | Sonida Senior Living, Inc. | 1.73B | -0.99% | 335,074 | 367.34M |
| 273 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | 0.43% | 335,256 | 923.71M |
| 274 | ADUS | Addus HomeCare Corporation | 1.72B | 0.90% | 229,070 | 1.45B |
| 275 | PLSE | Pulse Biosciences, Inc. | 1.71B | -4.92% | 303,349 | 751.00K |
| 276 | AGIO | Agios Pharmaceuticals, Inc. | 1.70B | 1.02% | 934,966 | 66.05M |
| 277 | BHVN | Biohaven Ltd. | 1.70B | 12.12% | 4,785,683 | - |
| 278 | CAPR | Capricor Therapeutics, Inc. | 1.69B | -0.75% | 553,687 | 11.13M |
| 279 | RXRX | Recursion Pharmaceuticals, Inc. | 1.68B | 6.73% | 26,463,017 | 66.41M |
| 280 | ANAB | AnaptysBio, Inc. | 1.68B | -0.14% | 666,859 | 232.39M |
| 281 | GENB | Generate Biomedicines, Inc. | 1.68B | -1.95% | 603,286 | 30.30M |
| 282 | PVLA | Palvella Therapeutics, Inc. | 1.67B | -1.13% | 113,664 | - |
| 283 | ABCL | AbCellera Biologics Inc. | 1.66B | 2.84% | 6,471,804 | 79.21M |
| 284 | TSHA | Taysha Gene Therapies, Inc. | 1.65B | 2.86% | 1,559,784 | 7.47M |
| 285 | NUVB | Nuvation Bio Inc. | 1.65B | 1.07% | 3,017,809 | 143.05M |
| 286 | INVA | Innoviva, Inc. | 1.63B | -2.43% | 597,486 | 420.69M |
| 287 | GLUE | Monte Rosa Therapeutics, Inc. | 1.62B | -0.16% | 572,559 | 42.95M |
| 288 | CMPS | COMPASS Pathways plc | 1.60B | -3.11% | 2,869,680 | - |
| 289 | AVAH | Aveanna Healthcare Holdings Inc. | 1.60B | 0.82% | 1,091,256 | 2.52B |
| 290 | SLS | SELLAS Life Sciences Group, Inc. | 1.60B | 5.67% | 9,219,863 | - |
| 291 | QURE | uniQure N.V. | 1.59B | 0.08% | 516,757 | 18.09M |
| 292 | ATAI | AtaiBeckley Inc. | 1.59B | 0.70% | 4,543,361 | 3.49M |
| 293 | PGEN | Precigen, Inc. | 1.57B | 3.77% | 5,752,759 | 31.60M |
| 294 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.56B | 2.85% | 580,254 | -665.00K |
| 295 | STAA | STAAR Surgical Company | 1.56B | -5.85% | 1,062,185 | 290.38M |
| 296 | DMRA | Damora Therapeutics, Inc. | 1.55B | -2.63% | 222,442 | - |
| 297 | PRGO | Perrigo Company plc | 1.54B | 3.33% | 3,417,091 | 4.18B |
| 298 | VIR | Vir Biotechnology, Inc. | 1.53B | -2.99% | 1,392,391 | 65.50M |
| 299 | GHRS | GH Research PLC | 1.53B | -3.41% | 223,205 | - |
| 300 | IMTX | Immatics N.V. | 1.53B | 1.79% | 504,475 | 43.00M |
| 301 | ARDX | Ardelyx, Inc. | 1.52B | -1.28% | 2,338,695 | 427.68M |
| 302 | MBX | MBX Biosciences, Inc. | 1.52B | 0.41% | 511,015 | - |
| 303 | INBX | Inhibrx Biosciences, Inc. | 1.51B | -3.60% | 243,766 | 1.30M |
| 304 | PRCT | PROCEPT BioRobotics Corporation | 1.51B | -3.61% | 1,050,782 | 322.02M |
| 305 | AGL | agilon health, inc. | 1.51B | 5.82% | 353,195 | 5.82B |
| 306 | IMCR | Immunocore Holdings plc | 1.45B | -3.03% | 521,225 | 412.81M |
| 307 | MAZE | Maze Therapeutics, Inc. | 1.44B | -1.14% | 401,888 | 20.00M |
| 308 | NNNN | Anbio Biotechnology | 1.44B | -0.67% | 20,291 | 8.65M |
| 309 | WGS | GeneDx Holdings Corp. | 1.43B | -2.49% | 1,165,834 | 442.68M |
| 310 | URGN | UroGen Pharma Ltd. | 1.43B | -0.44% | 496,942 | 140.49M |
| 311 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | -0.07% | 2,466,702 | 114.48M |
| 312 | BCAX | Bicara Therapeutics Inc. | 1.42B | -1.82% | 309,560 | - |
| 313 | HCSG | Healthcare Services Group, Inc. | 1.41B | 1.38% | 516,961 | 1.85B |
| 314 | ATRC | AtriCure, Inc. | 1.39B | -4.72% | 1,046,462 | 552.16M |
| 315 | AHCO | AdaptHealth Corp. | 1.38B | - | 825,773 | 3.29B |
| 316 | ARDT | Ardent Health, Inc. | 1.35B | 1.18% | 267,701 | 6.43B |
| 317 | SEPN | Septerna, Inc. | 1.34B | -2.81% | 178,699 | 72.26M |
| 318 | MLTX | MoonLake Immunotherapeutics | 1.34B | 0.99% | 928,670 | - |
| 319 | MPLT | MapLight Therapeutics, Inc. | 1.34B | 0.31% | 269,277 | - |
| 320 | AHG | Akso Health Group | 1.34B | -2.50% | 4,930 | 14.84M |
| 321 | PAHC | Phibro Animal Health Corporation | 1.33B | -2.35% | 390,422 | 1.50B |
| 322 | ENOV | Enovis Corporation | 1.33B | -4.82% | 1,289,399 | 2.28B |
| 323 | ALMR | Alamar Biosciences, Inc. | 1.33B | 0.16% | 210,958 | 87.16M |
| 324 | SVRA | Savara Inc. | 1.32B | 1.36% | 834,433 | - |
| 325 | HROW | Harrow, Inc. | 1.28B | 0.76% | 766,566 | 268.68M |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.28B | -1.68% | 433,603 | - |
| 327 | FTRE | Fortrea Holdings Inc. | 1.27B | 1.51% | 944,360 | 2.71B |
| 328 | COAG | Hemab Therapeutics Holdings, Inc. | 1.26B | 2.73% | 148,737 | - |
| 329 | NEO | NeoGenomics, Inc. | 1.25B | 3.24% | 861,621 | 745.97M |
| 330 | KMTS | Kestra Medical Technologies, Ltd. | 1.23B | -3.76% | 147,199 | 83.72M |
| 331 | BFLY | Butterfly Network, Inc. | 1.22B | 3.08% | 2,998,629 | 102.92M |
| 332 | WVE | Wave Life Sciences Ltd. | 1.22B | -0.63% | 2,567,431 | 71.80M |
| 333 | INSP | Inspire Medical Systems, Inc. | 1.22B | 0.55% | 1,067,196 | 915.25M |
| 334 | ATEC | Alphatec Holdings, Inc. | 1.20B | -2.85% | 2,509,339 | 787.08M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.20B | 1.96% | 723,706 | 101.66M |
| 336 | TDOC | Teladoc Health, Inc. | 1.19B | - | 3,319,116 | 2.51B |
| 337 | PNTG | The Pennant Group, Inc. | 1.18B | 0.24% | 146,467 | 1.02B |
| 338 | IART | Integra LifeSciences Holdings Corporation | 1.18B | - | 894,677 | 1.64B |
| 339 | IRMD | IRADIMED CORPORATION | 1.17B | -1.18% | 102,790 | 86.28M |
| 340 | AVNS | Avanos Medical, Inc. | 1.16B | 0.16% | 834,765 | 715.90M |
| 341 | CDNA | CareDx, Inc. | 1.14B | 2.88% | 472,818 | 412.82M |
| 342 | ZBIO | Zenas BioPharma, Inc. | 1.14B | -3.42% | 321,619 | 10.00M |
| 343 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.13B | -0.23% | 1,571,725 | 204.73M |
| 344 | OLMA | Olema Pharmaceuticals, Inc. | 1.13B | -4.72% | 958,225 | - |
| 345 | AVLN | Avalyn Pharma Inc. | 1.12B | 0.45% | 213,198 | - |
| 346 | DBVT | DBV Technologies S.A. | 1.11B | 1.87% | 1,319,995 | 5.74M |
| 347 | IVA | Inventiva S.A. | 1.11B | 1.16% | 151,361 | 7.94M |
| 348 | AORT | Artivion, Inc. | 1.10B | -1.85% | 487,571 | 458.69M |
| 349 | EYPT | EyePoint, Inc. | 1.10B | -1.42% | 1,825,964 | 7.61M |
| 350 | AKTS | Aktis Oncology, Inc. | 1.10B | -3.21% | 157,027 | 8.28M |
| 351 | MNKD | MannKind Corporation | 1.10B | 0.57% | 3,581,373 | 360.78M |
| 352 | COLL | Collegium Pharmaceutical, Inc. | 1.09B | -0.30% | 377,711 | 796.33M |
| 353 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | 0.78% | 1,244,907 | - |
| 354 | ALVO | Alvotech | 1.08B | 0.58% | 331,552 | 562.04M |
| 355 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | -0.48% | 959,451 | 314.85M |
| 356 | CNMD | CONMED Corporation | 1.07B | -1.61% | 592,116 | 1.37B |
| 357 | JBIO | Jade Biosciences, Inc. | 1.06B | -0.97% | 385,516 | - |
| 358 | AMN | AMN Healthcare Services, Inc. | 1.05B | -0.07% | 686,316 | 3.42B |
| 359 | EVO | Evotec SE | 1.03B | -1.37% | 20,064 | 859.03M |
| 360 | TNDM | Tandem Diabetes Care, Inc. | 1.02B | 1.93% | 2,758,625 | 1.03B |
| 361 | CRON | Cronos Group Inc. | 1.01B | -0.37% | 732,371 | 159.54M |
| 362 | INNV | InnovAge Holding Corp. | 1.01B | 1.09% | 178,871 | 949.17M |
| 363 | PSNL | Personalis, Inc. | 993.80M | 6.15% | 2,459,901 | 64.52M |
| 364 | SDGR | Schrödinger, Inc. | 989.30M | 0.68% | 1,067,269 | 254.91M |
| 365 | AZTA | Azenta, Inc. | 983.62M | 4.10% | 1,057,475 | 596.48M |
| 366 | OPK | OPKO Health, Inc. | 981.62M | 0.78% | 2,169,445 | 581.12M |
| 367 | OMDA | Omada Health, Inc. | 978.52M | 2.24% | 1,059,005 | 283.30M |
| 368 | USPH | U.S. Physical Therapy, Inc. | 976.59M | 3.32% | 188,944 | 787.69M |
| 369 | GDRX | GoodRx Holdings, Inc. | 968.61M | 2.88% | 2,016,257 | 787.89M |
| 370 | PHAR | Pharming Group N.V. | 967.33M | -1.54% | 4,779 | 369.49M |
| 371 | LXRX | Lexicon Pharmaceuticals, Inc. | 963.70M | 5.34% | 1,931,115 | 69.64M |
| 372 | SPTX | Seaport Therapeutics, Inc. | 957.15M | 0.22% | 118,655 | - |
| 373 | CGEM | Cullinan Therapeutics, Inc. | 953.83M | 0.39% | 1,344,996 | - |
| 374 | PCRX | Pacira BioSciences, Inc. | 945.92M | -1.31% | 303,724 | 734.86M |
| 375 | DRTS | Alpha Tau Medical Ltd. | 927.91M | -0.77% | 371,361 | - |
| 376 | ABUS | Arbutus Biopharma Corporation | 916.57M | - | 3,673,398 | 191.45M |
| 377 | MGTX | MeiraGTx Holdings plc | 915.91M | 3.02% | 715,945 | 79.76M |
| 378 | KURA | Kura Oncology, Inc. | 909.05M | -1.63% | 1,454,317 | 71.64M |
| 379 | ORIC | ORIC Pharmaceuticals, Inc. | 888.18M | 0.47% | 772,353 | - |
| 380 | ETON | Eton Pharmaceuticals, Inc. | 887.51M | 3.55% | 443,521 | 86.93M |
| 381 | ANNX | Annexon, Inc. | 883.11M | -2.36% | 1,931,018 | - |
| 382 | JANX | Janux Therapeutics, Inc. | 880.61M | 0.28% | 1,720,246 | 13.73M |
| 383 | INMD | InMode Ltd. | 874.98M | - | 1,024,481 | 374.64M |
| 384 | TALK | Talkspace, Inc. | 871.07M | - | 1,065,788 | 238.37M |
| 385 | XNCR | Xencor, Inc. | 868.94M | 0.77% | 484,450 | 97.36M |
| 386 | DRUG | Bright Minds Biosciences Inc. | 853.34M | 0.88% | 253,142 | - |
| 387 | PHAT | Phathom Pharmaceuticals, Inc. | 853.08M | -3.24% | 1,088,441 | 204.89M |
| 388 | SANA | Sana Biotechnology, Inc. | 851.57M | 0.33% | 3,545,312 | - |
| 389 | AURA | Aura Biosciences, Inc. | 844.89M | 0.66% | 266,943 | - |
| 390 | SPRY | ARS Pharmaceuticals, Inc. | 844.08M | 4.04% | 794,239 | 98.99M |
| 391 | AMPH | Amphastar Pharmaceuticals, Inc. | 842.17M | 1.54% | 501,592 | 720.53M |
| 392 | VOR | Vor Biopharma Inc. | 840.96M | 10.07% | 793,187 | - |
| 393 | QDEL | QuidelOrtho Corporation | 840.79M | 2.84% | 1,644,372 | 2.66B |
| 394 | EVMN | Evommune, Inc. | 840.67M | -0.04% | 346,518 | 10.00M |
| 395 | TBPH | Theravance Biopharma, Inc. | 838.25M | -0.91% | 322,259 | 109.78M |
| 396 | CERT | Certara, Inc. | 832.27M | 2.69% | 4,518,344 | 419.75M |
| 397 | AVR | Anteris Technologies Global Corp. | 832.14M | -2.42% | 1,059,216 | 1.85M |
| 398 | AVTX | Avalo Therapeutics, Inc. | 830.01M | -1.44% | 971,957 | 59.00K |
| 399 | CTMX | CytomX Therapeutics, Inc. | 829.45M | 3.25% | 4,764,339 | 35.54M |
| 400 | NUTX | Nutex Health Inc. | 821.98M | -3.04% | 116,378 | 879.95M |
| 401 | ODTX | Odyssey Therapeutics, Inc. | 810.92M | -2.11% | 405,167 | 2.98M |
| 402 | GERN | Geron Corporation | 808.32M | -1.56% | 8,286,827 | 196.12M |
| 403 | ESPR | Esperion Therapeutics, Inc. | 805.76M | 0.32% | 6,307,410 | 418.24M |
| 404 | ABSI | Absci Corporation | 804.47M | -2.27% | 2,503,836 | 1.84M |
| 405 | OMER | Omeros Corporation | 801.20M | -4.98% | 4,359,134 | 9.89M |
| 406 | LBRX | LB Pharmaceuticals Inc | 797.21M | -1.87% | 200,382 | - |
| 407 | ALLO | Allogene Therapeutics, Inc. | 776.60M | 6.13% | 10,690,278 | 22.00K |
| 408 | RLMD | Relmada Therapeutics, Inc. | 761.49M | 1.26% | 557,976 | - |
| 409 | BIOA | BioAge Labs, Inc. | 753.47M | 4.63% | 1,401,986 | 10.32M |
| 410 | SSII | SS Innovations International, Inc. | 751.77M | 0.80% | 85,992 | 48.47M |
| 411 | BVS | Bioventus Inc. | 743.46M | -1.33% | 1,057,230 | 576.30M |
| 412 | LMRI | Lumexa Imaging Holdings, Inc. | 741.74M | -5.51% | 465,393 | 1.03B |
| 413 | ANRO | Alto Neuroscience, Inc. | 716.48M | -2.94% | 153,202 | - |
| 414 | CBLL | CeriBell, Inc. | 709.53M | -0.53% | 122,213 | 95.07M |
| 415 | HSTM | HealthStream, Inc. | 708.47M | -0.49% | 169,955 | 311.78M |
| 416 | TENX | Tenax Therapeutics, Inc. | 699.47M | -0.83% | 497,606 | - |
| 417 | DSGN | Design Therapeutics, Inc. | 693.27M | -2.63% | 842,698 | - |
| 418 | SLDB | Solid Biosciences Inc. | 691.12M | 2.03% | 868,125 | - |
| 419 | CBIO | Crescent Biopharma, Inc. | 690.83M | 2.16% | 446,976 | 11.88M |
| 420 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 683.31M | 1.91% | 531,583 | - |
| 421 | SGP | SpyGlass Pharma, Inc. | 674.21M | -2.18% | 52,051 | - |
| 422 | CRMD | CorMedix Inc. | 663.70M | 2.30% | 1,088,878 | 400.05M |
| 423 | TLRY | Tilray Brands, Inc. | 662.02M | 1.83% | 3,330,705 | 858.28M |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 647.31M | 6.10% | 2,688,622 | 122.29M |
| 425 | CSTL | Castle Biosciences, Inc. | 644.81M | 7.97% | 626,063 | 339.92M |
| 426 | SIBN | SI-BONE, Inc. | 641.29M | -1.43% | 555,000 | 206.22M |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 639.66M | 1.55% | 683,560 | 8.37M |
| 428 | BWAY | BrainsWay Ltd. | 627.37M | -2.08% | 125,336 | 56.22M |
| 429 | CABA | Cabaletta Bio, Inc. | 624.50M | 2.96% | 5,351,481 | - |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 610.72M | -4.87% | 2,945,364 | 361.51M |
| 431 | IMMX | Immix Biopharma, Inc. | 609.27M | -1.24% | 1,605,831 | - |
| 432 | PRME | Prime Medicine, Inc. | 596.04M | 11.11% | 4,654,727 | 4.03M |
| 433 | VALN | Valneva SE | 592.74M | 4.79% | 72,242 | 180.25M |
| 434 | CADL | Candel Therapeutics, Inc. | 589.83M | 1.26% | 1,740,321 | - |
| 435 | NPCE | NeuroPace, Inc. | 581.64M | 2.28% | 127,035 | 99.53M |
| 436 | ALT | Altimmune, Inc. | 579.53M | 1.71% | 2,597,333 | 36.00K |
| 437 | AGMB | AgomAb Therapeutics NV | 574.72M | 5.61% | 55,302 | - |
| 438 | TECX | Tectonic Therapeutic, Inc. | 574.19M | 1.47% | 228,357 | - |
| 439 | CLYM | Climb Bio, Inc. | 571.31M | 5.00% | 1,029,658 | - |
| 440 | ARVN | Arvinas, Inc. | 571.01M | -0.78% | 583,260 | 89.40M |
| 441 | DNA | Ginkgo Bioworks Holdings, Inc. | 568.98M | 0.23% | 714,171 | 151.40M |
| 442 | TCMD | Tactile Systems Technology, Inc. | 565.49M | 0.04% | 196,869 | 343.52M |
| 443 | CERS | Cerus Corporation | 565.04M | 3.30% | 1,692,907 | 216.56M |
| 444 | TRAX | First Tracks Biotherapeutics, Inc. | 563.16M | -5.39% | 336,128 | - |
| 445 | EIKN | Eikon Therapeutics, Inc. | 561.42M | 4.75% | 374,940 | - |
| 446 | PHR | Phreesia, Inc. | 554.77M | 2.01% | 2,050,614 | 495.59M |
| 447 | PROK | ProKidney Corp. | 546.73M | 7.10% | 1,372,273 | 889.00K |
| 448 | RIGL | Rigel Pharmaceuticals, Inc. | 545.44M | 1.06% | 336,955 | 299.77M |
| 449 | SRTA | Strata Critical Medical, Inc. | 541.66M | 1.95% | 955,464 | 228.58M |
| 450 | GYRE | Gyre Therapeutics, Inc. | 540.92M | -0.34% | 80,399 | 117.05M |
| 451 | MDXG | MiMedx Group, Inc. | 537.69M | -1.63% | 756,417 | 389.42M |
| 452 | ASMB | Assembly Biosciences, Inc. | 527.48M | -4.70% | 148,992 | 71.10M |
| 453 | PRTA | Prothena Corporation plc | 525.10M | -0.30% | 616,188 | 57.94M |
| 454 | FBRX | Forte Biosciences, Inc. | 524.63M | -2.14% | 126,373 | - |
| 455 | XOMA | XOMA Royalty Corporation | 523.46M | 0.05% | 45,208 | 48.56M |
| 456 | KYTX | Kyverna Therapeutics, Inc. | 519.96M | -0.23% | 592,272 | - |
| 457 | BBNX | Beta Bionics, Inc. | 518.25M | -0.77% | 572,809 | 110.24M |
| 458 | CTKB | Cytek Biosciences, Inc. | 515.28M | 0.50% | 588,475 | 204.17M |
| 459 | FLGT | Fulgent Genetics, Inc. | 508.37M | 1.30% | 416,331 | 320.35M |
| 460 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 461 | CTNM | Contineum Therapeutics, Inc. | 502.47M | -1.90% | 148,404 | - |
| 462 | AQST | Aquestive Therapeutics, Inc. | 501.80M | -1.96% | 1,388,459 | 50.27M |
| 463 | ANGO | AngioDynamics, Inc. | 493.52M | 0.34% | 292,068 | 313.73M |
| 464 | STRO | Sutro Biopharma, Inc. | 491.90M | 8.44% | 321,528 | 99.61M |
| 465 | ACHV | Achieve Life Sciences, Inc. | 490.71M | 4.82% | 1,858,804 | - |
| 466 | CATX | Perspective Therapeutics, Inc. | 474.43M | - | 1,028,187 | 618.00K |
| 467 | EPRX | Eupraxia Pharmaceuticals Inc. | 468.45M | -4.65% | 170,935 | - |
| 468 | OCGN | Ocugen, Inc. | 467.16M | 2.99% | 5,308,546 | 4.47M |
| 469 | STTK | Shattuck Labs, Inc. | 464.68M | -0.82% | 318,563 | 1.00M |
| 470 | EBS | Emergent BioSolutions Inc. | 464.37M | -1.42% | 821,110 | 676.80M |
| 471 | FDMT | 4D Molecular Therapeutics, Inc. | 462.64M | 1.61% | 401,314 | 88.24M |
| 472 | KMDA | Kamada Ltd. | 461.70M | 0.38% | 49,954 | 181.68M |
| 473 | TOI | The Oncology Institute, Inc. | 460.92M | 0.44% | 1,165,323 | 545.76M |
| 474 | FULC | Fulcrum Therapeutics, Inc. | 451.77M | 0.30% | 325,992 | 80.00M |
| 475 | KIDS | OrthoPediatrics Corp. | 450.77M | -1.96% | 91,622 | 243.30M |
| 476 | UPB | Upstream Bio, Inc. | 449.51M | 0.61% | 420,408 | 3.32M |
| 477 | AUTL | Autolus Therapeutics plc | 447.12M | - | 1,531,810 | 92.62M |
| 478 | SGMT | Sagimet Biosciences Inc. | 445.85M | - | 820,350 | - |
| 479 | WEAV | Weave Communications, Inc. | 443.98M | -0.89% | 886,838 | 248.72M |
| 480 | ANL | Adlai Nortye Ltd. | 440.00M | -3.08% | 72,170 | 5.00M |
| 481 | OVID | Ovid Therapeutics Inc. | 439.51M | 3.67% | 962,519 | 7.12M |
| 482 | ADCT | ADC Therapeutics SA | 436.27M | -2.28% | 602,782 | 79.18M |
| 483 | MNPR | Monopar Therapeutics Inc. | 432.41M | 3.08% | 174,461 | - |
| 484 | NRC | NRC Health | 431.13M | 0.47% | 88,731 | 138.64M |
| 485 | VREX | Varex Imaging Corporation | 430.32M | 0.39% | 292,396 | 857.50M |
| 486 | MOBI | Mobia Medical, Inc. | 429.45M | -1.37% | 64,546 | 32.04M |
| 487 | NGNE | Neurogene Inc. | 424.60M | -0.85% | 97,710 | 925.00K |
| 488 | VTVT | vTv Therapeutics Inc. | 418.45M | 1.69% | 46,095 | 36.84M |
| 489 | EVH | Evolent Health, Inc. | 418.43M | -2.87% | 2,042,086 | 1.89B |
| 490 | PRLD | Prelude Therapeutics Incorporated | 418.40M | 1.71% | 170,883 | 16.72M |
| 491 | IPSC | Century Therapeutics, Inc. | 415.72M | 6.22% | 1,468,812 | 109.16M |
| 492 | LAB | Standard BioTools Inc. | 413.79M | -2.75% | 1,294,073 | 86.26M |
| 493 | CCCC | C4 Therapeutics, Inc. | 412.08M | 7.16% | 2,632,777 | 34.86M |
| 494 | CGC | Canopy Growth Corporation | 410.17M | 1.90% | 7,956,544 | 203.04M |
| 495 | ZURA | Zura Bio Limited | 408.94M | 2.38% | 597,796 | - |
| 496 | CMPX | Compass Therapeutics, Inc. | 408.80M | 3.18% | 6,726,137 | 850.00K |
| 497 | EOLS | Evolus, Inc. | 406.98M | -1.12% | 513,675 | 301.79M |
| 498 | CCRN | Cross Country Healthcare, Inc. | 405.28M | -0.08% | 339,935 | 1.00B |
| 499 | GLSI | Greenwich LifeSciences, Inc. | 404.97M | 6.72% | 178,980 | - |
| 500 | PACB | Pacific Biosciences of California, Inc. | 400.68M | 2.38% | 3,474,284 | 160.03M |